Risk Factors for PONV in Patients Undergoing Hysteroscopic Surgery
Risk Factors for Postoperative Nausea and Vomiting in Patients Undergoing Day-case Hysteroscopic Surgery
1 other identifier
observational
1,583
1 country
1
Brief Summary
The purpose of this study was to construct and validate a risk prediction model for PONV in patients undergoing hysteroscopic day-case surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 22, 2024
CompletedFirst Posted
Study publicly available on registry
July 29, 2024
CompletedJuly 29, 2024
July 1, 2024
3 years
July 22, 2024
July 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PONV
The occurrence and severity of PONV is evaluated by Visual Analogue Scale (VAS). The VAS scale ranges from 0 to 10, with larger scores meaning that the patient has more severe PONV.
Within 24 hours after surgery
Study Arms (2)
Observation group
The patient experience the postoperative nausea or vomiting
Control group
The patient did not experience postoperative nausea or vomiting
Interventions
This is a prospective risk prediction model building, thus there is no traditional definition of intervention.
This is a prospective risk prediction model building, thus there is no traditional definition of intervention.
Eligibility Criteria
Female patients undergoing gynaecological hysteroscopic day-case surgery.
You may qualify if:
- Female patients undergoing hysteroscopic day-case surgery and aged 18 years.
You may not qualify if:
- Patients with intraoperative change of surgical method and unstable postoperative vital signs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weifang People's Hospital
Weifang, Shandong, 265100, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Shirong Fang, Researcher
Weifang People's Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research investigator
Study Record Dates
First Submitted
July 22, 2024
First Posted
July 29, 2024
Study Start
January 1, 2021
Primary Completion
January 1, 2024
Study Completion
June 1, 2024
Last Updated
July 29, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share